Relevium Technologies Inc. (RLLVF)
| Previous Close | 0.0001 |
| Open | 0.0001 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0001 - 0.0001 |
| 52 Week Range | 0.0001 - 0.0105 |
| Volume | |
| Avg. Volume | 2,435 |
| Market Cap | 5.332M |
| Beta (5Y Monthly) | 2.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0270 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Relevium Announces Change in Auditors
MONTREAL, Aug. 09, 2022 (GLOBE NEWSWIRE) -- RELEVIUM TECHNOLOGIES INC. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its board of directors (the “Board”) has approved a change of the Company’s auditor. The Board has appointed Richter LLP (“Richter”) as the new auditor. At the request of Relevium, RSM Canada LLP (“RSM”) has resigned as the Company’s auditor effective as of August 5, 2022, and Richter was appointed as auditor of the Co
- GlobeNewswire
Relevium Provides Operational and Continued Disclosure Update
MONTREAL, April 21, 2022 (GLOBE NEWSWIRE) -- RELEVIUM TECHNOLOGIES INC. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on operations and continuous disclosure matters. UPDATE ON ONGOING OPERATIONS On December 16, 2021, the Company announced it had delivered 127.5 million medical grade nitrile gloves, representing 100% of the first of two PPE contracts that the Company had entered into for a total value of CAD$11M. On January 25 an
